Cargando…

液体活检及其在非小细胞肺癌诊治中的研究进展

With the advances of technology, great progresses have been made in liquid biopsy in recent years. Liquid biopsy is currently playing a more and more important role in early diagnosis and treatment of cancer. Compared with traditional tissue biopsy, liquid biopsy is more popular in clinical practice...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015208/
https://www.ncbi.nlm.nih.gov/pubmed/27335304
http://dx.doi.org/10.3779/j.issn.1009-3419.2016.06.19
_version_ 1783334362969800704
collection PubMed
description With the advances of technology, great progresses have been made in liquid biopsy in recent years. Liquid biopsy is currently playing a more and more important role in early diagnosis and treatment of cancer. Compared with traditional tissue biopsy, liquid biopsy is more popular in clinical practice due to its non-invasiveness, convenience and high repeatability. It has huge potential in the future. This review introduces circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) as the most important objects in liquid biopsy, mainly focusing on their history, biological characteristics, detection technologies, limitations and applications in non-small cell lung cancer.
format Online
Article
Text
id pubmed-6015208
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60152082018-07-06 液体活检及其在非小细胞肺癌诊治中的研究进展 Zhongguo Fei Ai Za Zhi 2016胸外医师年会特约专题:早期肺癌 With the advances of technology, great progresses have been made in liquid biopsy in recent years. Liquid biopsy is currently playing a more and more important role in early diagnosis and treatment of cancer. Compared with traditional tissue biopsy, liquid biopsy is more popular in clinical practice due to its non-invasiveness, convenience and high repeatability. It has huge potential in the future. This review introduces circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) as the most important objects in liquid biopsy, mainly focusing on their history, biological characteristics, detection technologies, limitations and applications in non-small cell lung cancer. 中国肺癌杂志编辑部 2016-06-20 /pmc/articles/PMC6015208/ /pubmed/27335304 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.06.19 Text en 版权所有©《中国肺癌杂志》编辑部2016 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 2016胸外医师年会特约专题:早期肺癌
液体活检及其在非小细胞肺癌诊治中的研究进展
title 液体活检及其在非小细胞肺癌诊治中的研究进展
title_full 液体活检及其在非小细胞肺癌诊治中的研究进展
title_fullStr 液体活检及其在非小细胞肺癌诊治中的研究进展
title_full_unstemmed 液体活检及其在非小细胞肺癌诊治中的研究进展
title_short 液体活检及其在非小细胞肺癌诊治中的研究进展
title_sort 液体活检及其在非小细胞肺癌诊治中的研究进展
topic 2016胸外医师年会特约专题:早期肺癌
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015208/
https://www.ncbi.nlm.nih.gov/pubmed/27335304
http://dx.doi.org/10.3779/j.issn.1009-3419.2016.06.19
work_keys_str_mv AT yètǐhuójiǎnjíqízàifēixiǎoxìbāofèiáizhěnzhìzhōngdeyánjiūjìnzhǎn
AT yètǐhuójiǎnjíqízàifēixiǎoxìbāofèiáizhěnzhìzhōngdeyánjiūjìnzhǎn